Mitotic arrest leads to a rapid loss of MCL-1 and induction of apoptosis in myeloma cells, whereas MM cells with sustained expression of anti-apoptotic molecules (e.g., BCL-xL) or the capability to evade via mitotic slippage are less prone to mitotic blockers [101]. The gene discussed is BCL2L1; the disease is plasma cell myeloma.